BIORAY BIOTECH CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.5 TWD | +0.38% |
|
+5.79% | -14.24% |
| 04-18 | Bioray Biotech Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Bioray Biotech Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| Sales 2022 | 191M 5.92M 8.1M | Sales 2023 | 192M 5.95M 8.16M | Capitalization | 930M 28.85M 39.53M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 0 | Net income 2023 | -11M -341K -468K | EV / Sales 2022 | 4.53 x |
| Net cash position 2022 | 38.16M 1.18M 1.62M | Net cash position 2023 | 27.23M 845K 1.16M | EV / Sales 2023 | 4.7 x |
| P/E ratio 2022 |
1,678
x | P/E ratio 2023 |
-80.4
x | Employees | - |
| Yield 2022 |
0.67% | Yield 2023 |
-
| Free-Float | 63.47% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.38% | ||
| 1 week | +5.79% | ||
| Current month | +10.88% | ||
| 1 month | +39.11% | ||
| 3 months | -2.75% | ||
| 6 months | -7.67% | ||
| Current year | -14.24% |
1 week
24.90
27.30
1 month
18.6527.30
Current year
18.5030.90
1 year
18.5035.30
3 years
18.5061.40
5 years
18.50111.50
10 years
18.50111.50
| Managers | Title | Age | Since |
|---|---|---|---|
Chun Mei Lue
CEO | Chief Executive Officer | - | 17-10-29 |
Cheng Shun Kuo
DFI | Director of Finance/CFO | - | - |
Yue Chiu Lu
CTO | Chief Tech/Sci/R&D Officer | - | 19-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Po Wen Huang
BRD | Director/Board Member | - | 20-03-03 |
Chun Mei Lue
CEO | Chief Executive Officer | - | 17-10-29 |
Ching Wen Wang
BRD | Director/Board Member | - | 20-03-03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-12 | 26.5 | +0.38% | 31,001 |
| 24-06-11 | 26.4 | -0.75% | 99,015 |
| 24-06-07 | 26.6 | +2.31% | 62,436 |
| 24-06-06 | 26 | -4.76% | 79,000 |
| 24-06-05 | 27.3 | +8.98% | 37,993 |
End-of-day quote Taipei Exchange, June 11, 2024
More quotes
Bioray Biotech Co Ltd is a Taiwan-based company mainly engaged in the production of health products, as well as the Own Designing & Manufacturing and Original Equipment Manufacturing (ODM/OEM) business. The Company also provides functional medical testing services, as well as cell storage and preparations business. The health products include personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, female urinary tract, anti-arthritis probiotics, among others. The testing services include personalized bacteria, personalized fungi, intestinal normal bacteria, quantitative detection of magnesium in red blood cells, polymorphism analysis of metabolic related genes, lymphocyte grouping. The cell storage and preparations include stem cell storage, immune cell storage, cytokine induced killer (CIK) immune cell preparations, among others.
Sector
Food Processing
| 1st Jan change | Capi. | |
|---|---|---|
| -14.24% | 24.5M | |
| +10.61% | 7.93B | |
| +2.60% | 7.42B | |
| +0.34% | 5.91B | |
| -7.20% | 3.7B | |
| -13.51% | 3.47B | |
| -25.75% | 1.17B | |
| -14.51% | 1.17B | |
| +10.42% | 949M | |
| -13.88% | 898M |
- Stock Market
- Equities
- 7561 Stock
